Deler fremragende | 24,315,086 shares |
Insideraktier | 15.464.267 shares |
Insider ejerskab | 63,60 % |
Total Insiders | 29 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
TetraLogic Pharmaceuticals Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Amgen Inc
10% Owner -
|
541.399 | 541.399 | |
Amgen Ventures LLC
10% Owner -
|
541.399 | 541.399 | |
J Kevin Buchi President & CEO, Director - [D] [O] | 330.714 | 330.714 | |
Colin Glenn Begley Chief Scientific Officer & SVP - [O] | 198.134 | 198.134 | |
James H Cavanaugh
10% Owner -
|
2.586.466 | 2.586.466 | |
Clarus Lifesciences II, L.P.
10% Owner -
|
2.214.523 | 2.214.523 | |
Geode Capital Management Lp | 1.257.144 | ||
John Gill Director - [D] | 40.312 | 40.312 | |
Mary Ann Gray | 30.000 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Brenda D Gavin Director - [D] | 948.268 | 948.268 | |
Healthcare Ventures Vii Lp
10% Owner -
|
2.586.466 | 2.586.466 | |
Hudson Bay Capital Management LP | 279.367 | ||
Patrick Hutchison CFO & Treasurer - [O] | 14.000 | 14.000 | |
Michael D Kishbauch | 30.000 | ||
Lazard Asset Management Llc | 1.463.594 | ||
Linden Advisors Lp | 2.095.239 | ||
Meyers Pete A. CFO & Treasurer - [O] | 153.891 | 153.891 | |
Nomura Securities International, Inc. | 892.850 | ||
Douglas E Onsi Director - [D] | 10.000 | 2.586.466 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Andrew L Pecora Director - [D] | 184.830 | 184.830 | |
Douglas MD Reed Director - [D] | 1.209.742 | 1.209.742 | |
Robins David C.
10% Owner -
|
6.000.000 | 6.000.000 | |
Lesley Russell Chief Operating Officer - [O] | 20.000 | 20.000 | |
Paul J Schmitt Director - [D] | 20.000 | 20.000 | |
Sherman Richard L. | 0 | ||
State of New Jersey Common Pension Fund D | 911.011 | ||
Telemetry Securities, L.l.c. | 838.094 | ||
Whitebox Advisors Llc | 3.018.260 | ||
Woody James N. Director - [D] | 1.001.988 | 1.001.988 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TLOG / TetraLogic Pharmaceuticals Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TLOG / TetraLogic Pharmaceuticals Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-06-27 | 3 | Robins David C. | TLOG | Common Stock | D | 6.000.000 | ||||||||
2018-06-27 | 3 | Robins David C. | TLOG | Common Stock | D | 6.000.000 | ||||||||
2018-06-27 | 3 | Robins David C. | TLOG | Common Stock | D | 6.000.000 | ||||||||
2016-11-14 | 2016-11-14 | 4 | LAZARD ASSET MANAGEMENT LLC | TLOG | 8% Senior Convertible Notes due 2024 | I | ||||||||
2016-11-14 | 2016-11-14 | 4 | LAZARD ASSET MANAGEMENT LLC | TLOG | Preferred Stock | I | 1.463.594 | 1.463.594 | ||||||
2016-11-14 | 2016-11-14 | 4 | LAZARD ASSET MANAGEMENT LLC | TLOG | 8% Senior Convertible Notes due 2019 | I | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | LINDEN ADVISORS LP | TLOG | Preferred Stock | I | 2.095.239 | 2.095.239 | ||||||
2016-11-14 | 2016-11-14 | 4 | LINDEN ADVISORS LP | TLOG | 8% Senior Convertible Notes due 2024 | I | ||||||||
2016-11-14 | 2016-11-14 | 4 | LINDEN ADVISORS LP | TLOG | 8% Senior Convertible Notes due 2019 | I | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | TELEMETRY SECURITIES, L.L.C. | TLOG | Preferred Stock | D | 838.094 | 838.094 | ||||||
2016-11-14 | 2016-11-14 | 4 | TELEMETRY SECURITIES, L.L.C. | TLOG | 8% Senior Convertible Notes due 2024 | D | ||||||||
2016-11-14 | 2016-11-14 | 4 | TELEMETRY SECURITIES, L.L.C. | TLOG | 8% Senior Convertible Notes due 2019 | D | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | GEODE CAPITAL MANAGEMENT LP | TLOG | Preferred Stock | I | 1.257.144 | 1.257.144 | ||||||
2016-11-14 | 2016-11-14 | 4 | GEODE CAPITAL MANAGEMENT LP | TLOG | 8% Senior Convertible Notes due 2024 | I | ||||||||
2016-11-14 | 2016-11-14 | 4 | GEODE CAPITAL MANAGEMENT LP | TLOG | 8% Senior Convertible Notes due 2019 | I | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | Hudson Bay Capital Management LP | TLOG | Preferred Stock | I | 279.367 | 279.367 | ||||||
2016-11-14 | 2016-11-14 | 4 | Hudson Bay Capital Management LP | TLOG | 8% Senior Convertible Notes due 2024 | I | ||||||||
2016-11-14 | 2016-11-14 | 4 | Hudson Bay Capital Management LP | TLOG | 8% Senior Convertible Notes due 2019 | I | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | State of New Jersey Common Pension Fund D | TLOG | 8% Convertible Notes due 2024 | I | ||||||||
2016-11-14 | 2016-11-14 | 4 | State of New Jersey Common Pension Fund D | TLOG | Preferred Stock | I | 911.011 | 911.011 | ||||||
2016-11-14 | 2016-11-14 | 4 | State of New Jersey Common Pension Fund D | TLOG | 8% Convertible Notes due 2019 | I | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | WHITEBOX ADVISORS LLC See Footnotes | TLOG | 8% Senior Convertible Notes due 2024 | I | ||||||||
2016-11-14 | 2016-11-14 | 4 | WHITEBOX ADVISORS LLC See Footnotes | TLOG | Preferred Stock | I | 3.018.260 | 3.018.260 | ||||||
2016-11-14 | 2016-11-14 | 4 | WHITEBOX ADVISORS LLC See Footnotes | TLOG | 8% Senior Convertible Notes due 2019 | I | 0 | |||||||
2016-11-14 | 2016-11-14 | 4 | NOMURA SECURITIES INTERNATIONAL, INC. | TLOG | Preferred Stock | D | 892.850 | 892.850 | ||||||
2016-11-14 | 2016-11-14 | 4 | NOMURA SECURITIES INTERNATIONAL, INC. | TLOG | 8% Convertible Notes due 2024 | D | ||||||||
2016-11-14 | 2016-11-14 | 4 | NOMURA SECURITIES INTERNATIONAL, INC. | TLOG | 8% Convertible Notes due 2019 | D | 0 | |||||||
2016-05-09 | 3 | Hutchison Patrick | TLOG | Common Stock | D | 14.000 | ||||||||
2016-05-09 | 3 | Hutchison Patrick | TLOG | Common Stock | D | 14.000 | ||||||||
2016-02-10 | 2016-02-09 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,1600 | -230.507 | -37 | 2.214.523 | ||||
2016-02-10 | 2016-02-08 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,1900 | -103.123 | -20 | 2.445.030 | ||||
2016-02-05 | 2016-02-05 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,2000 | -832.881 | -167 | 2.548.153 | ||||
2016-02-05 | 2016-02-04 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,1400 | -500.026 | -70 | 3.381.034 | ||||
2016-02-05 | 2016-02-03 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,1500 | -82.583 | -12 | 3.881.060 | ||||
2016-02-02 | 2016-02-02 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,1700 | -176.306 | -30 | 3.963.643 | ||||
2016-02-02 | 2016-02-01 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,2000 | -140.000 | -28 | 4.139.949 | ||||
2016-02-02 | 2016-01-29 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,2600 | -52.826 | -14 | 4.279.949 | ||||
2016-01-28 | 2016-01-28 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,2600 | -32.521 | -8 | 4.332.775 | ||||
2016-01-28 | 2016-01-27 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,2700 | -209.984 | -57 | 4.365.296 | ||||
2016-01-28 | 2016-01-26 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 0,3000 | -69.425 | -21 | 4.575.280 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,7900 | 9.200 | 26 | 184.830 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,7500 | 800 | 2 | 175.630 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,7450 | 7.608 | 21 | 174.830 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,7430 | 6.900 | 19 | 167.222 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,7370 | 10.000 | 27 | 160.322 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,6900 | 2.100 | 6 | 150.322 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,6590 | 908 | 2 | 148.222 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,6500 | 1.092 | 3 | 147.314 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,5700 | 92 | 0 | 146.222 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,5400 | 1.300 | 3 | 146.130 | ||||
2015-07-14 | 2015-07-10 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,4400 | 10.000 | 24 | 144.830 | ||||
2015-07-13 | 2015-07-09 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,4090 | 10.000 | 24 | 134.830 | ||||
2015-07-13 | 2015-07-09 | 4 | Pecora Andrew L | TLOG | Common Stock | D | 2,4000 | 40.000 | 96 | 124.830 | ||||
2015-07-06 | 2015-07-02 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 2,3366 | 6.500 | 15 | 20.000 | ||||
2015-07-06 | 2015-07-02 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 2,3340 | 3.500 | 8 | 13.500 | ||||
2015-03-31 | 2015-03-27 | 4 | Meyers Pete A. | TLOG | Common Stock | D | 4,3500 | 5.000 | 22 | 153.891 | ||||
2015-03-30 | 2015-03-26 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 4,2295 | 5.000 | 21 | 330.714 | ||||
2015-01-30 | 2015-01-28 | 4 | Schmitt Paul J | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 30.000 | |||
2015-01-30 | 2015-01-28 | 4 | Russell Lesley | TLOG | Restricted Stock Unit | D | 75.000 | 0 | ||||||
2015-01-30 | 2015-01-28 | 4 | Russell Lesley | TLOG | Stock Option | D | 5,25 | 5,2500 | 100.000 | 525 | 611.195 | |||
2015-01-30 | 2015-01-28 | 4 | Reed Douglas MD | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 30.000 | |||
2015-01-30 | 2015-01-28 | 4 | GRAY MARY ANN | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 30.000 | |||
2015-01-30 | 2015-01-28 | 4 | BUCHI J KEVIN | TLOG | Restricted Stock Unit | D | 150.000 | 0 | ||||||
2015-01-30 | 2015-01-28 | 4 | BUCHI J KEVIN | TLOG | Stock Option | D | 5,25 | 5,2500 | 200.000 | 1.050 | 1.222.389 | |||
2015-01-30 | 2015-01-28 | 4 | STEINMETZ MICHAEL | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 30.000 | |||
2015-01-30 | 2015-01-28 | 4 | KISHBAUCH MICHAEL D | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 30.000 | |||
2015-01-30 | 2015-01-28 | 4 | Meyers Pete A. | TLOG | Restricted Stock Unit | D | 75.000 | 0 | ||||||
2015-01-30 | 2015-01-28 | 4 | Meyers Pete A. | TLOG | Stock Option | D | 5,25 | 5,2500 | 100.000 | 525 | 611.195 | |||
2015-01-30 | 2015-01-28 | 4 | Begley Colin Glenn | TLOG | Restricted Stock Unit | D | 75.000 | 0 | ||||||
2015-01-30 | 2015-01-28 | 4 | Begley Colin Glenn | TLOG | Stock Option | D | 5,25 | 5,2500 | 100.000 | 525 | 173.705 | |||
2015-01-30 | 2015-01-28 | 4 | Sherman Richard L. | TLOG | Restricted Stock Unit | D | 75.000 | 0 | ||||||
2015-01-30 | 2015-01-28 | 4 | Sherman Richard L. | TLOG | Stock Option | D | 5,25 | 5,2500 | 100.000 | 525 | 424.705 | |||
2015-01-30 | 2015-01-28 | 4 | Woody James N. | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 30.000 | |||
2015-01-30 | 2015-01-28 | 4 | Pecora Andrew L | TLOG | Stock Option | D | 5,25 | 5,2500 | 10.000 | 52 | 77.644 | |||
2015-01-29 | 2015-01-28 | 4 | ONSI DOUGLAS E | TLOG | Stock Option (Right to Buy) | D | 5,25 | 10.000 | 10.000 | |||||
2015-01-09 | 2015-01-07 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 5,0362 | 5.000 | 25 | 325.714 | ||||
2014-12-12 | 2014-12-10 | 4 | Begley Colin Glenn | TLOG | Common Stock - Colin Glenn Begley | D | 6,1600 | 5.900 | 36 | 198.134 | ||||
2014-12-11 | 2014-12-09 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 6,0120 | 5.000 | 30 | 320.714 | ||||
2014-12-08 | 2014-12-04 | 4 | Meyers Pete A. | TLOG | Common Stock | D | 4,9400 | 1.034 | 5 | 148.891 | ||||
2014-12-04 | 2014-12-02 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 4,9900 | 10.000 | 50 | 315.714 | ||||
2014-12-01 | 2014-11-26 | 4 | Begley Colin Glenn By family member | TLOG | Common Stock, Ryan Alexander Begley (Son) | I | 4,8654 | 1.100 | 5 | 1.100 | ||||
2014-12-01 | 2014-11-26 | 4 | Begley Colin Glenn | TLOG | Common Stock, Colin Glenn Begley | D | 4,9000 | 1.000 | 5 | 192.234 | ||||
2014-12-01 | 2014-11-26 | 4 | Begley Colin Glenn | TLOG | Common Stock, Colin Glenn Begley | D | 4,8100 | 1.000 | 5 | 191.234 | ||||
2014-12-01 | 2014-11-26 | 4 | Russell Lesley | TLOG | Common Stock | D | 4,8985 | 20.000 | 98 | 20.000 | ||||
2014-11-28 | 2014-11-25 | 4 | Begley Colin Glenn | TLOG | Common Stock | D | 4,8400 | 100 | 0 | 190.234 | ||||
2014-11-28 | 2014-11-25 | 4 | Begley Colin Glenn | TLOG | Common Stock | D | 4,8400 | 200 | 1 | 190.134 | ||||
2014-11-28 | 2014-11-25 | 4 | Begley Colin Glenn | TLOG | Common Stock | D | 4,8470 | 500 | 2 | 189.934 | ||||
2014-11-28 | 2014-11-25 | 4 | Begley Colin Glenn | TLOG | Common Stock | D | 4,8450 | 500 | 2 | 189.434 | ||||
2014-11-28 | 2014-11-25 | 4 | Begley Colin Glenn | TLOG | Common Stock | D | 4,8699 | 700 | 3 | 188.934 | ||||
2014-11-20 | 2014-11-18 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 4,8185 | 10.000 | 48 | 305.714 | ||||
2014-11-19 | 2014-11-17 | 4 | Pecora Andrew L | TLOG | Common Stock | I | 4,5320 | 20.000 | 91 | 84.830 | ||||
2014-11-13 | 2014-11-11 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 3,9325 | 10.000 | 39 | 295.714 | ||||
2014-11-13 | 2014-11-12 | 4 | Meyers Pete A. | TLOG | Common Stock | D | 3,9780 | 5.000 | 20 | 147.857 | ||||
2014-11-12 | 2014-11-10 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 4,1352 | 10.000 | 41 | 10.000 | ||||
2014-11-12 | 2014-11-10 | 4 | Schmitt Paul J | TLOG | Common Stock | D | 4,0630 | 10.000 | 41 | 10.000 | ||||
2014-11-07 | 2014-11-05 | 4 | GRAY MARY ANN | TLOG | Stock Options (right to buy) | D | 3,87 | 20.000 | 20.000 | |||||
2014-11-07 | 2014-11-05 | 4 | KISHBAUCH MICHAEL D | TLOG | Stock Options (right to buy) | D | 3,87 | 20.000 | 20.000 | |||||
2014-06-09 | 2014-04-22 | 4 | Sherman Richard L. | TLOG | Stock Option (Right to Buy) | D | 6,65 | 100.000 | 324.705 | |||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD See footnotes | TLOG | Warrants | I | 6,40 | -7.590 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD See footnotes | TLOG | Convertible Notes | I | 7,00 | -278.315 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD See footnotes | TLOG | Series C Convertible Stock | I | -780.980 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD | TLOG | Common Stock | I | 6,4022 | 7.590 | 49 | 1.209.742 | ||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD | TLOG | Common Stock | I | 7,0000 | 278.315 | 1.948 | 1.202.152 | ||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD | TLOG | Common Stock | I | 780.980 | 923.837 | ||||||
2013-12-19 | 2013-12-17 | 4 | Reed Douglas MD | TLOG | Common Stock | I | 7,0000 | 142.857 | 1.000 | 142.857 | ||||
2013-12-19 | 2013-12-17 | 4 | BUCHI J KEVIN | TLOG | Stock Option | D | 7,00 | 7,0000 | 167.040 | 1.169 | 975.775 | |||
2013-12-19 | 2013-12-17 | 4 | BUCHI J KEVIN | TLOG | Common Stock | D | 7,0000 | 285.714 | 2.000 | 285.714 | ||||
2013-12-19 | 2013-12-17 | 4 | Russell Lesley | TLOG | Stock Option (right to purchase) | D | 7,00 | 7,0000 | 164.394 | 1.151 | 487.888 | |||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J See footnotes | TLOG | Series C Warrants | I | 6,40 | 6,4022 | -5.305 | -34 | 0 | |||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J See footnotes | TLOG | Convertible Notes | I | 7,00 | -193.863 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J See footnotes | TLOG | Series C Convertible Preferred Stock | I | -427.440 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J See footnotes | TLOG | Series B Convertible Preferred Stock | I | -179.738 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J See footnotes | TLOG | Series A Convertible Preferred Stock | I | -261.437 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 6,4022 | 5.305 | 34 | 1.512.962 | ||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 7,0000 | 193.863 | 1.357 | 1.507.657 | ||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 427.440 | 1.313.794 | ||||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 179.738 | 886.354 | ||||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 261.437 | 706.616 | ||||||
2013-12-19 | 2013-12-17 | 4 | Schmitt Paul J | TLOG | Common Stock | I | 7,0000 | 445.179 | 3.116 | 445.179 | ||||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Warrants | D | 6,40 | 6,4022 | -23.282 | -149 | 0 | |||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Convertible Notes | D | 7,00 | -853.416 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Series C Convertible Preferred Stock | D | -2.342.944 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 6,4022 | 23.282 | 149 | 4.644.705 | ||||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 7,0000 | 853.416 | 5.974 | 4.621.423 | ||||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 2.342.944 | 3.768.007 | ||||||
2013-12-19 | 2013-12-17 | 4 | Clarus Lifesciences II, L.P. | TLOG | Common Stock | D | 7,0000 | 1.425.063 | 9.975 | 1.425.063 | ||||
2013-12-19 | 2013-12-17 | 4 | Gavin Brenda D | TLOG | Convertible Notes | I | 7,00 | -48.183 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Gavin Brenda D | TLOG | Common Stock | I | 7,0000 | 48.183 | 337 | 948.268 | ||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L See footnotes | TLOG | Series C Warrants | I | 6,40 | -161 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L See footnotes | TLOG | Convertible Notes | I | 7,00 | -5.887 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L See footnotes | TLOG | Series C Convertible Preferred Stock | I | -16.055 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L | TLOG | Common Stock | I | 6,4022 | 161 | 1 | 64.830 | ||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L | TLOG | Common Stock | I | 7,0000 | 5.887 | 41 | 64.669 | ||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L | TLOG | Common Stock | I | 16.055 | 58.782 | ||||||
2013-12-19 | 2013-12-17 | 4 | Pecora Andrew L | TLOG | Common Stock | I | 7,0000 | 26.551 | 186 | 42.727 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series C Warrants | I | 6,40 | -71 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series C Warrants | I | 6,40 | -143 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series C Warrants | I | 6,40 | -2.850 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Convertible Notes | I | 7,00 | -2.602 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Convertible Notes | I | 7,00 | -5.205 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Convertible Notes | I | 7,00 | -104.118 | 0 | |||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series C Convertible Preferred Stock | I | -5.681 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series C Convertible Preferred Stock | I | -11.363 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series C Convertible Preferred Stock | I | -227.266 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series B Convertible Preferred Stock | I | -8.866 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series B Convertible Preferred Stock | I | -17.733 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Series B Convertible Preferred Stock | I | -354.663 | 0 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 6,4022 | 71 | 0 | 1.001.988 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 6,4022 | 143 | 1 | 1.001.917 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 6,4022 | 2.850 | 18 | 1.001.774 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 7,0000 | 2.602 | 18 | 998.924 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 7,0000 | 5.205 | 36 | 996.322 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 7,0000 | 104.118 | 729 | 991.117 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 5.681 | 886.999 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 11.363 | 881.318 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 227.266 | 869.955 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 8.866 | 642.689 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 17.733 | 633.823 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 354.663 | 616.090 | ||||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 7,0000 | 6.079 | 43 | 261.427 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 7,0000 | 12.159 | 85 | 255.348 | ||||
2013-12-19 | 2013-12-17 | 4 | Woody James N. See footnotes | TLOG | Common Stock | I | 7,0000 | 243.189 | 1.702 | 243.189 | ||||
2013-12-19 | 2013-12-17 | 4 | Meyers Pete A. | TLOG | Stock Option | D | 7,00 | 7,0000 | 164.394 | 1.151 | 487.888 | |||
2013-12-19 | 2013-12-17 | 4 | Meyers Pete A. | TLOG | Common Stock | D | 7,0000 | 142.857 | 1.000 | 142.857 | ||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Series C Convertible Preferred Stock Warrants (Right To Buy) | I | 6,40 | -13.355 | 0 | |||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Convertible Notes | I | 7,00 | 0 | ||||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC | TLOG | Convertible Notes | D | 7,00 | 0 | ||||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Series C Convertible Preferred Stock | I | -117.361 | 0 | ||||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Series B Convertible Preferred Stock | I | -108.932 | 0 | ||||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Common Stock | I | 7,0000 | 272.142 | 1.905 | 541.399 | ||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Common Stock | I | 6,4022 | 1.141 | 7 | 269.257 | ||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC By Ventures | TLOG | Common Stock | I | 268.116 | 268.116 | ||||||
2013-12-18 | 2013-12-17 | 4 | AMGEN INC | TLOG | Common Stock | D | 448.767 | 448.767 | ||||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Notes | I | 7,00 | 0 | ||||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Series A Preferred Stock | I | 0,00 | -5.000.000 | 0 | |||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Preferred Stock Warrant | I | 6,40 | 0 | ||||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Series C Preferred Stock | I | 0,00 | -8.603.477 | 0 | |||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Series B Preferred Stock | I | 0,00 | -7.453.704 | 0 | |||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Common Stock | I | 7,0000 | 713.463 | 4.994 | 2.586.466 | ||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Common Stock | I | 7,0000 | 267.535 | 1.873 | 1.873.003 | ||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Common Stock | I | 6,4022 | 7.335 | 47 | 1.605.468 | ||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Common Stock | I | 506.086 | 1.598.133 | ||||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Common Stock | I | 438.453 | 1.092.047 | ||||||
2013-12-17 | 2013-12-17 | 4 | HEALTHCARE VENTURES VII LP | TLOG | Common Stock | I | 653.594 | 653.594 | ||||||
2013-12-11 | 3 | CAVANAUGH JAMES H | TLOG | Common Stock | D | 0 | ||||||||
2013-12-11 | 3 | GILL JOHN | TLOG | Common Stock | D | 40.312 | ||||||||
2013-12-11 | 3 | Gavin Brenda D By: Quaker BioVentures Tobacco Fund, L.P. | TLOG | Common Stock | I | 275.245 | ||||||||
2013-12-11 | 3 | Gavin Brenda D By: BioAdvance Ventures, L.P. | TLOG | Common Stock | I | 175.518 | ||||||||
2013-12-11 | 3 | Gavin Brenda D By: Quaker BioVentures, L.P. | TLOG | Common Stock | I | 449.322 | ||||||||
2013-12-11 | 3 | Pecora Andrew L | TLOG | Common Stock | D | 16.176 | ||||||||
2013-12-11 | 3 | Begley Colin Glenn | TLOG | Common Stock | D | 141.176 | ||||||||
2013-12-11 | 3 | Begley Colin Glenn | TLOG | Common Stock | D | 47.058 |